Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational, Real-life Study of the Use of octaplasLG®.

NCT03369314 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.

NCT NCT03369314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational, Real-life Study of the Use of octaplasLG®.
Lead sponsor
Octapharma
Phase
Observational
Overall status
Completed
Start date
March 2, 2018
Completion date
January 14, 2021
Enrollment
263 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

thrombotic thrombocytopenic purpura